Clinical Trial Update: Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing IL-5 in Children With Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating nebulized resveratrol with carboxymethyl-β-glucan to reduce IL-5 in children with allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Nebulized resveratrol plus carboxymethyl-β-glucan

Snippet

Sponsor: Istituto per la Ricerca e l'Innovazione Biomedica | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED